According to the World Bank, more than 50,000 different types of Medical Device are currently being used every day in health care facilities worldwide. In 2018, the global medical devices market is estimated to reach a net worth of approximately USD 450 billion. However, a relatively larger proportion of device developers lack the required internal resources and technical expertise to conduct in-house clinical trials. Moreover, the costs associated with acquiring the necessary infrastructure / capabilities for such elaborate research initiatives are high. The aforementioned challenges have led several players in the industry to outsource a significant part of their clinical stage research efforts to capable contract research organizations (CROs).
Presently, more than 300 CROs are actively engaged in providing a variety of preclinical and clinical services to medical device developers
Majority of the players are based in developed regions; in addition to established players, several start-ups / small sized companies offer services for medical device development.
Companies involved in this domain are steadily expanding their capabilities to enhance the range of services they offer and comply to existing industry benchmarks.
Close to 7,000 clinical trials, focused on medical devices, have been registered across the globe in the last five years, highlighting the increasing demand for contract service providers
In order to comply with multiple regional regulatory standards, a number of CROs have already established capabilities to offer support services in this area.
The domain has witnessed over 30 acquisitions, valued between USD 100 million and USD 5 billion, in past six years alone.
With a potential of over USD 10 billion, the market will continue to be led primarily by the clinical service providers over the coming decade.
Driven by the growing demand for effective treatment modalities across various therapeutic areas, the market is poised to witness sustained growth across different device classes
Clinical operations management is anticipated to lead the pack in the mid-long term; companies based in North America are expected to retain the higher market share.
Arun is an enthusiastic professional and has been associated with Roots Analysis since the very early years. He has led multifaceted roles over the years be it business research, consulting, competitive intelligence, IT & technology, sales and marketing. He currently drives strategic thinking and execution within the sales and marketing domain. With educational background in life sciences from Thapar University and digital marketing credentials from Indian School of Business, he has led a lot of critical initiatives at the organization. His background in life sciences has been one of the key reasons for quick understanding and implementation of customized marketing strategies. During his early years, he has led multiple consulting assignments for global clients ranging from competitive landscaping, deal structuring and preparing go-to-market strategy for his clients.